Financials
- Financial year
- 2025
- Total assets
- €10,778
- Loss
- -€8,620
- Solvency
- 59.2%
GIOS BIOSTRUCTURES
ActiveSummary
The annual accounts of GIOS BIOSTRUCTURES for financial year 2025 show a net loss of 80% of total assets. The 2025 annual accounts show equity of €6,380 and a net result of -€8,620. Its solvency ranks better than 49% of 613 sector peers (NACE 72, financial year 2025). The company has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals. The computed 12-month bankruptcy probability is 0.2% (very low).
Overview
Activity
Research and development on biotechnology
NACE 72101
1 site
Size
€10,778total assets 2025
- Equity
- €6,380
- Loss
- -€8,620
Turnover not published (micro format)
Why 55raises riskCapped at 59: a net loss of at least half of total assets or of the equity at the start of the financial yearLoss of €8,620 (financial year 2025)lowers riskSector: Scientific research and development (NACE 72)Liquidity: current ratio 1.55, cash €5,845Size: total assets €10,778Show the evidence
Checked score
Score 2025
55
/ 100
Fair
Probability in this band: 1.5% to 4.2%
Financially better than 43% of its sector peers (NACE 72, micro)
A net loss of at least half of total assets or of the equity at the start of the financial year caps the score at 59. Every signal that counts is listed under Signals.
Financial strength
Average
Solvency
84
equity 59.2% of total assets
Liquidity
81
short-term debt 40.8% · cash 54.2%
Profitability
0
return on assets -80.0%
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
05-2026: 0.7%
06-2026: 0.7%● unchanged vs 05-2026
07-2026: 0.7%● unchanged vs 06-2026highest value
08-2026: 0.2%▼ -0.5 percentage points vs 07-2026lowest value
09-2026: 0.2%● unchanged vs 08-2026
10-2026: 0.2%● unchanged vs 09-2026
No publishable credit limit; credit only on tighter terms
Net loss of at least half of total assets or of the equity at the start of the financial year.
Liquidity ample (current ratio 1.55, above the usual 1.5; short-term debt: 40.8% and cash: 54.2% of total assets), and 40.8% of the assets are financed with debt and provisions.
How it is calculated
The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 72, micro): better than 52% on solvency, 68% on liquidity and 10% on profitability.
The bankruptcy probability was computed on 26-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).
Credit check for your own amount and term
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
Six signals.
lowers riskraises riskneutral
raises risk · Young company
Founded in 2025, a year ago. Young companies fail more often than established ones; the risk is highest 2 to 8 years after founding.
KBO · incorporation dateAge against the risk zone
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-07-2026, 0 days ahead of the deadline.
NBB · 1 filingDeviation from the deadline
2025
on the day
← before the deadline
after the deadline →
Searched, nothing found (1)
- Annual accounts filedfinancial year 2025 · micro…
- IncorporationAppointments: STALMANS Giel François Hendrika…
Key points
By topic
Board & ownership
- Board
- 2 members
- OSIPOV EvgeniiDirector
- STALMANS Giel François HendrikaDirector
Timeline
- Events
- 2
- Since
- 2025
Company details
- Sites
- 1
- Legal form
- Private limited company
- Activity
- Research and development on biotechnologyNACE 72101
- Founded
- 03-04-2025
- Year ends
- 31-12
- Peppol
- Reachable for e-invoices
Articles of association
- Provisions read
- 5
- Annual meeting
- First Friday of June at 21:00
Key facts about GIOS BIOSTRUCTURES
- What is the company number of GIOS BIOSTRUCTURES?
- 1021.930.236. In Belgium the VAT number is the company number with BE in front: BE 1021.930.236.
- Where is GIOS BIOSTRUCTURES based?
- The registered office is at Zandstraat(SHL) 29, 3910 Pelt.Company details
- What does GIOS BIOSTRUCTURES do?
- According to the KBO register, the main activity is research and development on biotechnology (NACE 72101).
- What is the legal form of GIOS BIOSTRUCTURES?
- Private limited company (BV).
- When was GIOS BIOSTRUCTURES founded?
- On 03-04-2025.
- Is GIOS BIOSTRUCTURES still active?
- Yes, GIOS BIOSTRUCTURES is an active enterprise in the KBO register.
- What is the turnover of GIOS BIOSTRUCTURES?
- Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.Financials
- Is GIOS BIOSTRUCTURES profitable?
- In financial year 2025, GIOS BIOSTRUCTURES made a loss of €8,620.
- Where can I find the annual accounts of GIOS BIOSTRUCTURES?
- GIOS BIOSTRUCTURES filed 1 annual account with the National Bank of Belgium, for financial year 2025.
Companies related to GIOS BIOSTRUCTURES
Comparable companies
- BONTKasterlee
- Novocure BelgiumSint-Joost-ten-Node
- ODUXIOElsene
- PFx BiotechGent
- LABORATOIRES PARIS ELYSEESMouscron
Go further with this company
How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark Roughly what is this company worth?Value indication
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.